$TDSGF News
Last published 11mo ago
- 11mo agoCBWTFCCDSFCLOQDPLS+5Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online ViewingGlobeNewswireNEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference,
- 11mo agoTDSGFTelo Genomics Corp to Present at the Small Cap Growth Virtual Investor Conference December 9thGlobeNewswireTORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSXV:TELO, OTCQB:TDSGF), based in Toronto, a leader in diagnostic and prognostic innovation through its proprietary multi-factor telomere analytics
- 11mo agoCBWTFCCDSFCLOQDPLS+5Small Cap Growth Virtual Investor Conference Agenda Announced for December 9thGlobeNewswireNEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the Small Cap Growth Virtual Investor Conference to be held
- 1y agoAAGAFCLGOFCYBHFISRJF+9OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online ViewingGlobeNewswireNEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the OTCQB Venture Virtual Investor Conference, held
- 1y agoTDSGFTelo Genomics to Present at the OTCQB Venture Virtual Investor ConferenceGlobeNewswireTORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSXV:TELO, OTCQB:TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through
- 1y agoAAGAFCLGOFCYBHFISRJF+10OTCQB Venture Virtual Investor Conference Agenda Announced for August 7thGlobeNewswireNEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the OTCQB Venture Virtual Investor Conference to be held August 7th.
- 2y agoBMYNEONTRATDSGF+1Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030GlobeNewswirePALM BEACH, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Recent reports show that the Multiple myeloma Diagnostic market will continue to grow in the next several years. Multiple myeloma is